| Product NDC: | 0832-0513 |
| Proprietary Name: | Bethanechol Chloride |
| Non Proprietary Name: | Bethanechol Chloride |
| Active Ingredient(s): | 50 mg/1 & nbsp; Bethanechol Chloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0832-0513 |
| Labeler Name: | Upsher-Smith Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040636 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100124 |
| Package NDC: | 0832-0513-50 |
| Package Description: | 500 TABLET in 1 BOTTLE (0832-0513-50) |
| NDC Code | 0832-0513-50 |
| Proprietary Name | Bethanechol Chloride |
| Package Description | 500 TABLET in 1 BOTTLE (0832-0513-50) |
| Product NDC | 0832-0513 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bethanechol Chloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100124 |
| Marketing Category Name | ANDA |
| Labeler Name | Upsher-Smith Laboratories, Inc. |
| Substance Name | BETHANECHOL CHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cholinergic Muscarinic Agonist [EPC],Cholinergic Muscarinic Agonists [MoA] |